CliffBio
small molecule

FYCOMPA

PERAMPANEL

Loss of exclusivityJuly 2026latest FDA-listed patent expiry
CompanyCatalyst →View the full company profile on CliffBio

Drug detail

Brand nameFYCOMPA
Active ingredientPERAMPANEL
Strength0.5MG/ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalApril 2016
Marketing statusRX

Listed patents

PatentExpiresType
8772497July 2026substance

More from Catalyst

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

FYCOMPA patent cliff — loss of exclusivity July 2026 | CliffBio